Day: April 13, 2020

ENGLEWOOD, Colo., April 13, 2020 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) announced that Dr. Patrick R. Gruber, Chief Executive Officer of Gevo, Inc., will participate and present in the alphaDIRECT Advisors Virtual Conference Series on April 14, 2020, at 12:00 pm EDT / 10:00 am MDT as part of the alphaDIRECT Investor Intelligence Program.Dr. Gruber will present on Gevo’s Low Carbon, Clean Fuels followed by a question and answer session. The presentation will be webcast live and available for replay under the Investor Relations page found on www.gevo.com and under alphaDIRECT Advisors center page at www.alphadirectadvisors.com.Registration Link:https://globalmeet.webcasts.com/starthere.jsp?ei=1304371&tp_key=9b5624f4c0About GevoGevo is commercializing the next generation of jet fuel, gasoline and diesel fuel with the potential...

NEW YORK, NY, April 13, 2020 (GLOBE NEWSWIRE) — PharmaCyte Biotech (OTCQB: PMCB) is a California-based biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, and while it continues to focus on submitting an Investigational New Drug application (IND) to the U.S. Food and Drug Administration (FDA) for its treatment for locally advanced, inoperable pancreatic cancer, it has also seized an opportunity to offer testing kits for the coronavirus disease (COVID-19).  According to the company’s investor relations, this opportunity would create a revenue stream for its pancreatic cancer program.The virus—known as “Severe Acute Respiratory Syndrome Coronavirus 2” or “SARS-CoV-2,” causes the disease COVID-19, which has become a global pandemic...

-To Provide Clinical Development Update on CAP-1002--Final HOPE-2 Data Now Expected by Mid-Q2-LOS ANGELES, April 13, 2020 (GLOBE NEWSWIRE) —  Capricor Therapeutics (NASDAQ: CAPR) a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment or prevention of serious diseases, today announced that it will host a Key Opinion Leader (KOL) call on the cardiac complications of DMD on Wednesday, April 15, 2020 at 1:30 pm Eastern Time.The call will feature a presentation by key opinion leader Michael Taylor, M.D., Ph.D. (Cincinnati Children’s Hospital), Director of Advanced Imaging Innovation. Dr. Taylor will provide an overview of Duchenne muscular dystrophy, particularly focusing on the cardiac complications of the disease, its progression and current cardiac treatment...

CALGARY, Alberta, April 13, 2020 (GLOBE NEWSWIRE) — Canoe Financial LP today announced the launch of Canoe Defensive Global Balanced Fund, an actively managed solution that will offer investors innovative and proven downside protection while maintaining the ability to generate returns in up markets.The Fund will include investment strategies managed by three award-winning portfolio management teams: Canoe Financial, Fiera Capital Corporation, and Aegon USA Investment Management, LLC.“Canoe Defensive Global Balanced Fund will have the capability to protect against stock market volatility beyond the traditional balanced funds in the industry,” said Darcy Hulston, President and CEO of Canoe Financial. Nadim Rizk and the Global Equity Team from Fiera Capital will manage the equity allocation of the portfolio.  It will include the proprietary...

GRAND CAYMAN, Cayman Islands, April 13, 2020 (GLOBE NEWSWIRE) — Greenlight Capital Re, Ltd. (NASDAQ: GLRE) (“Greenlight Re” or the “Company”), a global specialty property and casualty reinsurer headquartered in the Cayman Islands, today announced preliminary, unaudited financial estimates of its results of operations for the quarter ended March 31, 2020.On a preliminary estimated basis:The Company expects its results of operations for the quarter ended March 31, 2020 to reflect:A net loss of $38 million to $43 million or ($1.05) to ($1.19) per fully diluted share.Net premiums written of $107 million to $112 millionNet premiums earned of $109 million to $114 millionAn underwriting loss of $1 million to an underwriting gain of $4 millionA composite ratio of 96% to 100%A combined ratio of 97% to 101%An investment loss in the Solasglas...

– Company Ramping Up WatchPAT™ ONE Production Capacity to Meet Demand for Disposable Home Sleep Apnea Tests –

SANTA CLARA, Calif., April 13, 2020 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS), (the “Company”, or “Borqs”), a global leader in embedded software and products for the Internet of Things (IoT) industry, today announced that the Company has received a line of credit offer of up to US$150 million from a financing group for working capital needs for the Company’s customer pre-orders forecasted at over US$100 million.  The orders are for mobile and IoT devices with Borqs’ embedded software scheduled for delivery beginning in the 2nd quarter of 2020 and extending into the year 2021.The available funds will be primarily used for Borqs development of customized hardware products, integrated with the Company’s propriety software, to major international customers. Such products include IoT and mobile terminal devices for the...

OTTAWA, April 13, 2020 (GLOBE NEWSWIRE) — HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced the closing of its previously announced underwritten public offering (the “Offering”) for total gross proceeds to the Company of approximately C$46 million. The Company sold 59,800,000 units of the Company (the “Units”) at a price of C$0.77 per Unit under the Offering, including 7,800,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.Each Unit is comprised of one common share of the Company and one common share purchase warrant of the Company. Each warrant is exercisable to acquire one common share of the Company for a period of 5 years following the closing date of the Offering at an exercise price of C$0.96 per share, subject to adjustment in certain events.Canaccord Genuity...

OTTAWA, 13 avr. 2020 (GLOBE NEWSWIRE) — HEXO Corp. (« HEXO », ou la « Société ») (TSX : HEXO ; NYSE : HEXO) a annoncé aujourd’hui la clôture de son placement public par prise ferme précédemment publié (le « placement »), pour un produit brut total pour la Société d’environ 46 million de dollars canadiens. La Société a vendu 59 800 000 unités de la Société (les « unités ») au prix de 0,77 dollars canadiens par unité dans le cadre du placement, y compris 7 800 000 unités vendues en vertu de l’exercice intégral par les preneurs fermes de leur option de surallocation.Chaque unité est composée d’une action ordinaire de la Société et d’un bon de souscription d’action ordinaire de la Société. Chaque bon de souscription peut être exercé pour acquérir une action ordinaire de la Société pendant une période de 5 ans...

BALTIMORE, April 13, 2020 (GLOBE NEWSWIRE) — Laureate Education, Inc. (NASDAQ: LAUR) plans to release results for the quarter ended March 31, 2020, on Thursday, May 7, 2020, before the stock market opens. Following the release, the Company will host a telephone conference call with investors and analysts at 8:30 a.m. ET to discuss the first quarter results and the Company’s business outlook.Interested parties are invited to listen to the earnings conference call by dialing 1-855-307-2849 (for U.S.- based callers), or 1-703-639-1262 (for international callers), and requesting to join the Laureate Education conference call, conference ID 8368663. Replays of the entire call will be available through May 14, 2020 at 1-855-859-2056 (for U.S.- based callers) and at 1-404-537-3406 (internationally), conference ID 8368663.The webcast...